GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Quantrx Biomedical Corp (OTCPK:QTXB) » Definitions » Cyclically Adjusted PB Ratio

Quantrx Biomedical (Quantrx Biomedical) Cyclically Adjusted PB Ratio : (As of Jun. 04, 2024)


View and export this data going back to . Start your Free Trial

What is Quantrx Biomedical Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Quantrx Biomedical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Quantrx Biomedical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantrx Biomedical Cyclically Adjusted PB Ratio Chart

Quantrx Biomedical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Quantrx Biomedical Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Quantrx Biomedical's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Quantrx Biomedical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quantrx Biomedical's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Quantrx Biomedical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Quantrx Biomedical's Cyclically Adjusted PB Ratio falls into.



Quantrx Biomedical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Quantrx Biomedical's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2022 is calculated as:

For example, Quantrx Biomedical's adjusted Book Value per Share data for the three months ended in Sep. 2022 was:

Adj_Book=Book Value per Share/CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=-0.037/125.2265*125.2265
=-0.037

Current CPI (Sep. 2022) = 125.2265.

Quantrx Biomedical Quarterly Data

Book Value per Share CPI Adj_Book
201212 -0.011 96.871 -0.014
201303 -0.012 98.209 -0.015
201306 -0.013 98.518 -0.017
201309 -0.014 98.790 -0.018
201312 -0.017 98.326 -0.022
201403 -0.020 99.695 -0.025
201406 -0.018 100.560 -0.022
201409 -0.018 100.428 -0.022
201412 -0.022 99.070 -0.028
201503 -0.023 99.621 -0.029
201506 -0.022 100.684 -0.027
201509 -0.023 100.392 -0.029
201512 -0.023 99.792 -0.029
201603 -0.024 100.470 -0.030
201606 -0.026 101.688 -0.032
201609 -0.022 101.861 -0.027
201612 -0.023 101.863 -0.028
201703 -0.025 102.862 -0.030
201706 -0.026 103.349 -0.032
201709 -0.027 104.136 -0.032
201712 -0.012 104.011 -0.014
201803 -0.013 105.290 -0.015
201806 -0.014 106.317 -0.016
201809 -0.013 106.507 -0.015
201812 -0.020 105.998 -0.024
201903 -0.021 107.251 -0.025
201906 -0.023 108.070 -0.027
201909 -0.024 108.329 -0.028
201912 -0.028 108.420 -0.032
202003 -0.028 108.902 -0.032
202006 -0.029 108.767 -0.033
202009 -0.030 109.815 -0.034
202012 -0.031 109.897 -0.035
202103 -0.032 111.754 -0.036
202106 -0.033 114.631 -0.036
202109 -0.034 115.734 -0.037
202112 -0.034 117.630 -0.036
202203 -0.035 121.301 -0.036
202206 -0.036 125.017 -0.036
202209 -0.037 125.227 -0.037

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Quantrx Biomedical  (OTCPK:QTXB) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Quantrx Biomedical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Quantrx Biomedical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Quantrx Biomedical (Quantrx Biomedical) Business Description

Traded in Other Exchanges
N/A
Address
10190 SW 90th Avenue, Tualatin, OR, USA, 97062
Quantrx Biomedical Corp operates towards the development and commercialization of patented mini form pad (PAD) based products. The PAD products are based on the company's non-woven disposable absorbent pad technology and it is involved in the PAD-based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its platforms include inSync(R), Unique(TM), and OEM branded over-the-counter and laboratory testing products.
Executives
Michael S Abrams director 64 RAMSHEAD ROAD, RAYNHAM MA 02767
Patrick T Mooney director C/O SONTRA MEDICAL CORPORATION, 10 FORGE PARKWAY, FRANKLIN MA 02038
Robert G. Pinco director 1700 K STREET NW, SUITE 300, WASHINGTON DC 20006
Hayes Arthur H Jr director 320 WAKARA WAY, SALT LAKE CITY UT 84108
Matthew Balk 10 percent owner 229 WEST 60TH STREET, NEW YORK NY 10023
Evan Levine director, 10 percent owner 1517 SAN JACINTO ST., HOUSTON TX 77002
Hayes Arthur Hull Jr director C/O QUANTRX BIOMEDICAL CORPORATION, 100 S. MAIN STREET, SUITE 300, DOYLESTOWN PA 18901
Cindy Horton officer: V.P. of Diagnostics 209 BRITTANY PARK, ANDERSON SC 29621
Sasha Afanassiev officer: Officer 120 GARRISON COURT, LANGHORNE PA 19047
Shalom Hirschman officer: Officer 5240 BLACKSTONE AVENUE, RIVERDALE NY 10471
William H Fleming director, officer: Secretary
Walter W Witoshkin director, officer: President and CEO 321 NORRISTOWN ROAD, SUITE 230, AMBLE PA 19002
Mark Capital Llc 10 percent owner 5173 SEAGROVE PLACE, SAN DIEGO CA 92130
Sherbrooke Partners, Llc 10 percent owner 570 LEXINGTON AVENUE, FLOOR 3, NEW YORK NY 10022
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282

Quantrx Biomedical (Quantrx Biomedical) Headlines

No Headlines